Topoisomerase Inhibitor
Showing 1 - 25 of 7,493
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +16 more
- Elimusertib
- +2 more
-
Phoenix, Arizona
- +10 more
Mar 25, 2022
Advanced Cancer Trial in Guangzhou (TQB2102 injection)
Not yet recruiting
- Advanced Cancer
- TQB2102 injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 23, 2023
Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States
Recruiting
- Metastatic Colorectal Carcinoma
- +29 more
- Berzosertib
- Irinotecan Hydrochloride
-
Los Angeles, California
- +22 more
Jun 28, 2022
Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol
Completed
- Metastatic Non Small Cell Lung Cancer
- Recurrent Non Small Cell Lung Cancer
- Etirinotecan pegol (NKTR-102)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 1, 2020
Recurrent Small Cell Lung Carcinoma Trial in Buffalo, Rochester (Laboratory Biomarker Analysis, Pegylated Irinotecan,
Completed
- Recurrent Small Cell Lung Carcinoma
- Laboratory Biomarker Analysis
- +2 more
-
Buffalo, New York
- +2 more
Mar 3, 2020
Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)
Completed
- Gliomas
- Topotecan
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jun 30, 2022
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023
HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,
Recruiting
- Acute Myeloid Leukemia
- Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
- Venetoclax-Decitabine/Azacitidine Association
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Breast Cancer Trial in China (TQB2102 for injection)
Not yet recruiting
- Breast Cancer
- TQB2102 for injection
-
Hefei, Anhui, China
- +20 more
Nov 1, 2023
Cancer Trial (Empagliflozin 10 MG)
Not yet recruiting
- Cancer
- Empagliflozin 10 MG
- (no location specified)
Oct 22, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)
Completed
- Adenocarcinoma, Gastric
- Neoplasm, Breast
-
Taipei, Taiwan
- +1 more
Nov 2, 2022